Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HIF3A |
| Upstream (Parents) |
|---|
| (<<) SOX11 → HIF3A |
| (<<) MYT1 → HIF3A |
| (<<) HOPX → HIF3A |
| (<<) SMAD6 → HIF3A |
| (<<) PRRX1 → HIF3A |
| (<<) TADA2A → HIF3A |
| (<<) HOXA5 → HIF3A |
| (<<) BLZF1 → HIF3A |
| (<<) POU6F1 → HIF3A |
| (<<) ALX1 → HIF3A |
| (<<) NKX2-8 → HIF3A |
| (<<) SOX15 → HIF3A |
| (<<) FOXL1 → HIF3A |
| (<<) SMAD4 → HIF3A |
| Downstream (Children) |
|---|
| HIF3A → DMRT1 (>>) |
| HIF3A → PHOX2B (>>) |
| HIF3A → CITED1 (>>) |
| HIF3A → NR0B1 (>>) |
| HIF3A → BARX1 (>>) |
| HIF3A → PDX1 (>>) |
| HIF3A → TSC22D4 (>>) |
| HIF3A → ZNF444 (>>) |
| HIF3A → HMX1 (>>) |
| HIF3A → CREB5 (>>) |
| HIF3A → RFX3 (>>) |
